Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Today Bahrain.
GCC Pharmaceutical Market To Surpass USD 12 Billion Opportunity By 2030
Delhi, Dec. 05, 2024 (GLOBE NEWSWIRE) -- GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030 Report Highlights: GCC Pharmaceutical Market Opportunity: > US$ 12 Billion By 2030 Saudi Arabia Domination GCC Pharmaceutical Market...
GFH Launches OUTLIVE in City Scape: An innovative Real Estate Venture rooted in Health & Well-being
GFH Launches OUTLIVE in City Scape: An innovative Real Estate Venture rooted in Health & Well-being BAHRAIN, November 27, 2024 /EINPresswire.com/ -- GFH Financial Group (“GFH”) today announced the launch of OUTLIVE in Cityscape, an innovative...
Beyon Unveils its Visionary Digital City at Gateway Gulf Forum Bahrain
Beyon Signs Digital City Development Agreement with Edamah, the real estate arm of Bahrain Mumtalakat Holding Company (Mumtalakat) MANAMA, BAHRAIN, November 4, 2024 /EINPresswire.com/ -- Beyon BSC (Ticker: BEYON), unveiled plans for its...
Global Hospital Information System Market Set to Reach USD 484.50 Billion by 2032, Growing at 17.34% CAGR
Demand for efficient healthcare management drives Hospital Information System market growth, enhancing patient care, data security & operational efficiency. AUSTIN, TX, UNITED STATES, October 31, 2024 /EINPresswire.com/ -- According to SNS...
Midwakh pipe smoking posing ‘significant’ health problems in UAE, scientists find
Despite health risks, a traditional smoking practice known as midwakh is booming in the UAE and other countries in Arabian Peninsula. SHARJAH, EMIRATE OF SHARJAH, UNITED ARAB EMIRATES, November 5, 2024 /EINPresswire.com/ -- A traditional type of...
YouMakr.ai Expands to Bahrain, Strengthening Its Presence in the Middle East
Bahrain has been selected as the ideal location for YouMakr’s Middle Eastern operations due to its strategic position as a gateway to the GCC LONDON, UNITED KINGDOM, October 16, 2024 /EINPresswire.com/ -- YouMakr.ai, a trailblazer in artificial...
NSA Bahrain, NAVSEA Conduct Annual Oil Spill Response Training Exercise
The five-day exercise aimed to demonstrate SUPSALV’s readiness in deploying its Tier II and III spill response capabilities from the Emergency Ship Salvage Material (ESSM) base, and to increase the overall proficiency of all personnel involved in...
Owner: American Government
Sima Ved & Sham Al Zahabi, Two Visionary Women Join Forces to Launch Dao Clinic in Dubai, Introducing Cutting-Edge Wellness and Beauty Solutions to the Region
DUBAI, United Arab Emirates, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Apparel Group, a global leader in retail and lifestyle, is proud to announce the grand opening of Dao Clinic Dubai, a dermatological and aesthetic care clinic set to transform the...
Sofitel Bahrain Zallaq Thalassa Sea & Spa: Sustainable Practices Saves Food and Local Animals
Green Globe has awarded Sofitel Bahrain Zallaq Thalassa Sea & Spa its inaugural certification in acknowledgement of its sustainable management and operations. SANTA MONICA, CA, UNITED STATES, October 25, 2024 /EINPresswire.com/ -- Green Globe...
Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries
Pratteln, Switzerland, 19 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi...
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025
DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 31, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted in vitro data assessing the effects of EPA on lipoprotein(a) [Lp(a)] oxidation and on cellular stress and inflammatory...
New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or Very High-Risk Patients Based on REDUCE-IT -- DUBLIN and BRIDGEWATER, N.J., Aug. 30, 2025 (GLOBE NEWSWIRE)...
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025
DUBLIN and BRIDGEWATER, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced upcoming presentations at the European Society of Cardiology (ESC) Congress 2025, August 29th-September 1st, in Madrid, Spain,...
ANR Overseas Launches Fast and Reliable Attestation Services for Gulf Countries
ANR Overseas launches specialized certificate attestation services for UAE, Qatar, Saudi Arabia, and other Gulf countries with doorstep and online support. DELHI, DELHI, INDIA, September 12, 2025 /EINPresswire.com/ -- New Delhi, India –...
Auerbach Hematology and Oncology Joins American Oncology Network, Becomes The Center for Cancer and Blood Disorders – Baltimore
BALTIMORE, July 15, 2025 (GLOBE NEWSWIRE) -- Auerbach Hematology and Oncology Associates PC, a trusted name in hematology and oncology care in Baltimore, Maryland, is proud to announce it has joined American Oncology Network (AON), one of the...
Money20/20 Middle East Secures Powerhouse of Founding Partners for 2025 Saudi Launch
RIYADH, SAUDI ARABIA, September 7, 2025 /EINPresswire.com/ -- AlRajhi Bank, Riyad Bank, STC Bank, Saudi National Bank, Tamara, Visa and Vision Bank lead a powerful coalition of financial innovators supporting the region's premier fintech...
AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML
PRESS RELEASE AB SCIENCE RECEIVES REGULATORY APPROVAL FROM EUROPEAN COUNTRIES TO INITIATE THIRD STAGE OF PHASE I/II STUDY COMBINING ITS MOLECULE AB8939 WITH VENETOCLAX FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA THE COMBINATION OF AB8939 TARGETING...
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA’s Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the Middle East and North Africa, in 2024 to...
Assistive Reproductive Technology Market Projected To Witness Massive Growth till 2025-2032 | Vitrolife AB, Merck KGaA
BURLINGAME, CA, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- The Global Assistive Reproductive Technology Market size is estimated to be valued at USD 34.8 billion in 2025 and is expected to reach USD 58.6 billion by 2032, exhibiting a...